Highest-materiality recent filing
Skyward Specialty shareholders re-elect two directors, approve say-on-pay, ratify EY auditor
Peter C. Hearn re-elected with 34,790,416 votes for, 901,506 withheld.
Skyward Q1 net income rises to $49.7M ($1.09) from $42.1M; operating income up to $56.8M
Net income $49.7M ($1.09 diluted EPS) vs $42.1M ($1.01) in Q1 2025.
Skyward Specialty files Apollo financials; Apollo net profit $49.7M in 2025
Apollo gross written premium $405.9M in 2025, down from $661.4M in 2024.
Effective April 1, 2026, CEO Andrew Robinson gets at least $1,100,000 base salary, 150% bonus target, and minimum $4,000,000 annual equity award.
Skyward Specialty Q4 net income $43.2M ($1.03 EPS) vs $14.4M; gross premiums up 13.2%
Net income of $43.2M ($1.03 diluted EPS) vs $14.4M ($0.35) in Q4 2024; full-year net income $170.0M ($4.07) vs $118.8M ($2.87).
Skyward Specialty closes $555M acquisition of Apollo, financed with $300M debt facility
Total consideration $555M: $371M cash plus 3,679,332 shares of SKWD common stock.
Skyward Specialty gets regulatory and minority approval for Apollo acquisition, issues 2026 guidance
Received regulatory and minority shareholder approvals for Apollo Group acquisition; closing expected early Q1 2026.
Skyward Specialty enters $150M revolving credit facility, expands to $250M on Apollo close
Skyward entered new $150M unsecured revolving credit facility, increasing to $250M upon closing of Apollo Group acquisition.
Skyward Specialty elects Christopher Peirce to board; Creager not to stand for re-election
Christopher Peirce elected Class III director effective Feb 1, 2026; expected to become Audit Committee Chair after 2025 10-K filing.
Skyward Specialty Q3 net income $45.9M ($1.10 EPS); premiums jump 51.6%
Net income of $45.9M ($1.10 diluted EPS) vs $36.7M ($0.89) in Q3 2024.
Acquisition consideration: $555M total, ~33% in stock (3.68M SKWD shares) and remainder cash, funded via committed $300M term loan from Barclays.
Skyward Specialty Q2 net income $38.8M, EPS $0.93; premiums up 17.9%
Net income $38.8M ($0.93 diluted EPS) vs $31.0M ($0.75) in Q2 2024, up 25%.
Skyward Specialty Insurance Group Announces Leadership Transition in Captives and Specialty Programs
Kirby Hill transitions to Chairman of Captives and Specialty Programs, remaining Executive Vice President.
Skyward Specialty Q1 net income $42.1M ($1.01 EPS) vs $36.8M year ago; premiums up 16.7%
Net income $42.1M ($1.01 diluted EPS) vs $36.8M ($0.90) in Q1 2024.
Skyward Specialty Q4 adjusted EPS $0.80, gross premiums +20.8%, book value +18%
Net income $14.4M ($0.35 diluted EPS) vs $29.3M ($0.74) a year ago.
Commuted LPT with R&Q Re, received $11.7M cash; strengthened reserves $25.3M, recognized $9.8M uncollectible reinsurance recoverable (net of tax).
Skyward Specialty Q3 net income $36.7M ($0.89 EPS); authorizes $50M buyback
Q3 net income $36.7M ($0.89 diluted EPS) vs $21.7M ($0.57) in Q3 2023.
Subsidiary enters $57M FHLB term loan at 4.00% fixed rate, maturing in 4.5 years
Houston Specialty Insurance Co., wholly owned subsidiary, borrowed $57M from the Federal Home Loan Bank of Dallas.
Skyward Specialty Q2 net income $31.0M ($0.75 EPS) vs $19.5M YoY; adj. op. income $33.1M
Q2 net income $31.0M ($0.75 diluted EPS) vs $19.5M ($0.51) YoY; adjusted operating income $33.1M ($0.80) vs $16.0M ($0.42).
Skyward Specialty shareholders elect three directors, ratify auditor at annual meeting
Andrew Robinson elected with 29.6M for, 1.9M withheld; 3.1M broker non-votes.
Westaim launches secondary offering of 4.4M Skyward Specialty shares at $36.50 each
Selling stockholder Westaim HIIG GP Inc. offers 4,400,000 shares of SKWD common stock at $36.50 per share.
Skyward Specialty Q1 net income $36.8M ($0.90 EPS); adjusted EPS $0.75
Net income $36.8M ($0.90 diluted EPS) vs $15.6M ($0.42) in Q1 2023.
Skyward Specialty Q4 net income $29.3M ($0.74 EPS); full-year $86.0M; premiums up 21.4%
Q4 net income $29.3M (diluted EPS $0.74) vs $20.4M ($0.63) YoY; adjusted operating income $24.3M ($0.61) vs $11.6M ($0.36).
Skyward Specialty appoints Michael Morrissey, CFA to Board; to chair Investment Committee
Mike Morrissey appointed to Skyward Specialty Board as Class II director, effective Dec 14, 2023.
Skyward Specialty Insurance Group board resignations and appointments effective November 30, 2023
Directors Cameron MacDonald and Robert Kittel resigned from the board effective November 30, 2023, not due to any dispute.
Skyward Specialty Q3 net income $21.7M vs loss; combined ratio improves to 90.2%
Net income $21.7M ($0.57 diluted EPS) vs net loss $2.4M ($0.15 loss) in Q3 2022.
Skyward Specialty appoints Gena Ashe to Board as independent director effective Aug 14, 2023
Gena L. Ashe elected as Class I director; term expires at 2026 annual meeting.
Skyward Specialty Q2 net income triples to $19.5M; gross written premiums up 29.4%
Net income $19.5M ($0.51/sh) vs $5.1M ($0.16) in Q2 2022; adjusted operating income $16.0M ($0.42) vs $16.4M ($0.50).
Skyward Specialty annual meeting elects directors and ratifies EY as auditor
James Hays re-elected with 26,104,635 votes for, 915,394 withheld, 306,450 broker non-votes.
Skyward Specialty Appoints Anthony J. Kuczinski to Board of Directors
Appointed as Class III director effective August 1, 2023, with term expiring at 2025 annual meeting.
Skyward Specialty Q1 net income $15.6M ($0.42/sh); gross written premiums +27.5%
Net income $15.6M, $0.42 diluted EPS; adjusted operating income $15.5M, $0.42 diluted EPS.
Skyward Specialty enters $150M credit facility with Truist, replaces prior bank debt
$150M revolving credit facility; up to $30M for letters of credit; accordion feature allows $50M increase to $200M.
Skyward Specialty Q4 net income $20.4M ($0.63/dil) vs $1.3M YoY; combined ratio improves to 92.4%
Q4 net income $20.4M ($0.63/dil) vs $1.3M ($0.04) YoY; adjusted op. income $11.6M ($0.36/dil) vs $7.6M ($0.23).
Skyward Specialty closes upsized IPO of 8.95M shares at $15; begins trading on Nasdaq
IPO priced at $15.00 per share for 8,952,383 total shares: 4,750,000 new shares from company, 4,202,383 from selling stockholders.
Corey LaFlamme has been recruited and will assume the role of President, Captives and Specialty Programs with oversight of operational matters for the divisions.
Kirby Hill, the Company’s Executive Vice President and President, Captives and Specialty Programs, will transition to the role of Chairman of Captives and Specialty Programs, focusing principally on key business development and strategic matters for the divisions.
On December 14, 2023 , the board of directors (“Board”) of Skyward Specialty Insurance Group, Inc. , a Delaware corporation (the “Company,” “we,” or “our”), appointed Mike Morrissey, CFA to our Board, effective December 14, 2023.
and Anthony J. Kuczinski to serve as our independent Lead Director of the Board
On November 27, 2023, Cameron MacDonald notified the board of directors (“Board”) of Skyward Specialty Insurance Group, Inc. , a Delaware corporation (the “Company,” “we,” or “our”), of his intention to resign as a director of the Company.
the Board appointed Andrew Robinson, the Company’s Chief Executive Officer, to serve as Chair of the Board
On November 29, 2023, Robert Kittel notified the Board of his intention to resign as a director of the Company.
the board of directors (“Board”) of Skyward Specialty Insurance Group, Inc., a Delaware corporation (the “Company,” “we,” or “our”), appointed Gena L. Ashe to our Board, effective August 14, 2023.
appointed Anthony J. Kuczinski to our Board, effective August 1, 2023.
Max materiality 0.90 · Median 0.70 · Most common event earnings